Basically three studies. Patients with non-resectable liver metastases from primary colorectal carcinoma. These are international multi-centre open label studies. These ongoing studies will recruit several hundreds of patients in many countries around the Globe. Approximately 608,000 deaths from colorectal cancer are estimated worldwide, accounting for 8% of all cancer deaths, making it the fourth most common...